Related Experiment Video
Updated: Jun 21, 2026
17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
A case for a new paradigm in genetic toxicology testing
Lynn H Pottenger1, B Bhaskar Gollapudi
1Toxicology & Environmental Research and Consulting, The Dow Chemical Company, Midland, MI 48674, USA. lpottenger@dow.com
Mutation Research
|July 21, 2009
Summary
Genetic toxicology needs updated methods for better risk assessment. Understanding dose-response, even for DNA-reactive chemicals, reveals thresholds, improving chemical safety evaluations.
Area of Science:
- Toxicology
- Genetics
- Molecular Biology
Background:
- Current genetic toxicology methods require modernization for improved risk assessment.
- The traditional view of genotoxicity as an inherent property is challenged by new mechanistic insights.
- A deeper understanding of mutation mechanisms necessitates a re-evaluation of genotoxicity testing.
Purpose of the Study:
- To advocate for a paradigm shift in genetic toxicology, emphasizing dose-response relationships.
- To highlight the importance of understanding internal/effective doses for accurate risk assessment.
- To promote the integration of mechanistic data into genotoxicity testing strategies.
Main Methods:
- Re-evaluating the application of dose-response principles in genotoxicity studies.
- Investigating the existence of thresholds (NOAELs) for genotoxic effects, including DNA-reactive agents.
- Improving the characterization of dose-response curves by considering internal/effective doses.
Main Results:
- Growing evidence supports the existence of thresholds for genotoxic effects, even with DNA-reactive chemicals.
- Understanding effective doses enhances dose-response curve characterization and cross-species extrapolation.
- Updated approaches can significantly improve the utility of genotoxicity data for risk assessment.
Conclusions:
- A focus on dose-response and internal dosimetry is crucial for advancing genetic toxicology.
- Modernized experimental designs and data interpretation are essential for 21st-century risk assessment.
- This shift will enhance the reliability and applicability of genotoxicity data in regulatory science.
Related Concept Videos
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:16In vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:16In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.